Topic List : Health Policy
Conference on children, immigration
The Child Health and Immigration Conference on May 25 will bring together Stanford researchers, policymakers and community leaders to discuss the effects of immigration policies on kids.
Dementia care falls mainly on women
As the population ages, a surge in patients with dementia will place an inordinate burden on working women, risking “hard-fought gains for equality in the workplace,” according to Stanford researchers.
Children’s health care on the line
If Medicaid funding is compromised, it destabilizes the entire children’s health care system on two fronts, writes the president and CEO of Stanford Children’s Health.
Gun sales spiked after mass shootings
In the six weeks after the Newtown and San Bernardino mass shootings, handguns sales jumped in California, yet there is little research on why — or on the implications for public health, according to a Stanford researcher.
Initial hospital costs of gun injuries $6.6 billion
Stanford researchers report that the $6.6 billion figure is just the tip of the iceberg: It does not include costs of emergency room visits or hospital readmissions.
Bias hunters looking in the right places
The biggest single source of bias across all fields of science comes from so-called small-study effects, Stanford researchers report.
Experts: Funding ban harms women
“The reinstatement of the Mexico City policy is a stark example of ‘evidence-free’ policy making that ignores the best scientific data,” Nathan Lo and Michele Barry write.
Fighting for children’s health care
The health policy decisions made in Sacramento and Washington, D.C., impact health care programs, and these changes trickle down to communities where the results are deeply felt.
Care delivery ‘black box’ of health economics
A physician and economist, Chan aims to shed light on why costs and patient outcomes can vary widely, even from one hospital to the next in the same city.
Owens on new statin recommendation
The Stanford professor of medicine was a member of the U.S. Preventive Services Task Force, which has issued a new recommendation on statin use based on an extensive literature review.